
Shanghai Shyndec Stock Hits Day Low of CNY 10.40 Amid Price Pressure
2025-10-31 17:12:07Shanghai Shyndec Pharmaceutical Co., Ltd. saw its stock decline significantly, reflecting ongoing performance challenges. The company reported a decrease in net sales and operating cash flow, alongside rising raw material costs. Despite a relatively attractive valuation, its year-to-date performance lags behind the broader market.
Read MoreNo announcement available
Corporate Actions
No corporate action available






